Summit Therapeutics Inc.
SMMT NASDAQHealthcare ★★★★★Latest Earnings Below forecast↓
Date
Jul 23, 2026
ET
EPS Est.
-0.27
EPS Actual
-0.28
Revenue Est.
$113889
Revenue Actual
--
Next Earnings Report
Date
Oct 19, 2026 · Mon
Time
Time TBD
Fiscal Period
FY2026 Q3
EPS Est.
-0.28
Revenue Est.
$71429
Company Overview
Summit Therapeutics Inc. (ticker SMMT) is listed on NASDAQ with a market cap of about $13.37B. Its next earnings report (FY2026 Q3) is expected on Oct 19, 2026 (ET), Time TBD, with consensus EPS of -0.28. In the last 11 reported quarters, EPS beat consensus estimates 5 times.
Actual EPS TrendRecently15Term · Mar 9, 2023 → Jul 23, 2026
Mar 9, 2023Range: -0.76 ~ -0.02Jul 23, 2026
Earnings History
| Date | Fiscal Period | EPS Est. | EPS Actual | Revenue Est. | Revenue Actual |
|---|---|---|---|---|---|
| Jul 23, 2026 | -- | -0.27 | Below forecast↓-0.28 | $113889 | -- |
| Apr 30, 2026 | -- | -0.33 | Above forecast↑-0.24 | $54420 | -- |
| Feb 23, 2026 | -- | -0.10 | Below forecast↓-0.29 | $56.8M | -- |
| Oct 20, 2025 | -- | -0.18 | Below forecast↓-0.31 | $76.5M | -- |
| Aug 11, 2025 | -- | -0.09 | Below forecast↓-0.76 | -- | -- |
| May 1, 2025 | -- | -0.09 | -0.09 | -- | -- |
| Feb 24, 2025 | -- | -0.08 | -0.08 | -- | -- |
| Oct 30, 2024 | -- | -0.07 | Below forecast↓-0.08 | -- | -- |
| Aug 6, 2024 | -- | -0.06 | Above forecast↑-0.05 | -- | -- |
| May 1, 2024 | -- | -0.06 | -0.06 | -- | -- |
| Feb 20, 2024 | -- | -- | -0.04 | -- | -- |
| Nov 7, 2023 | -- | -- | -0.03 | -- | -- |
| Aug 9, 2023 | -- | -- | -0.02 | -- | $235000 |
| May 11, 2023 | -- | -- | -0.06 | -- | -- |
| Mar 9, 2023 | -- | -0.26 | Above forecast↑-0.07 | -- | $705 |
Original Filings (SEC)
Quarterly10-Q · 2026-07-23 ↗
Earnings Release8-K · 2026-07-23 ↗
Quarterly10-Q · 2026-04-30 ↗
Earnings Release8-K · 2026-04-30 ↗
Annual10-K · 2026-02-23 ↗
Earnings Release8-K · 2026-02-23 ↗
Earnings Release8-K · 2025-10-20 ↗
Earnings Release8-K · 2025-08-11 ↗
Links point to the company's original filings on the U.S. Securities and Exchange Commission (SEC) website. For some foreign private issuers (ADRs), the earnings filing is typically submitted to the SEC several days after the results are announced; it will appear here automatically once filed.
Report dates are US trading days (Eastern Time); EPS and revenue estimates are market consensus, in USD. This page is for reference only and does not constitute investment advice.
